Tyrosine kinase inhibitors concentration monitoring in chronic myeloid leukemia.
| Data(s) |
2010
|
|---|---|
| Identificador |
https://serval.unil.ch/?id=serval:BIB_A87914EAC621 isbn:1873-5835[electronic], 0145-2126[linking] pmid:20074797 doi:10.1016/j.leukres.2009.12.009 isiid:000276946200003 |
| Idioma(s) |
en |
| Fonte |
Leukemia Research, vol. 34, no. 6, pp. 698-699 |
| Palavras-Chave | #Antineoplastic Agents/administration & dosage; Antineoplastic Agents/adverse effects; Blood Chemical Analysis/methods; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism; Monitoring, Physiologic/methods; Osmolar Concentration; Patient Compliance; Protein Kinase Inhibitors/administration & dosage; Protein Kinase Inhibitors/adverse effects; Protein-Tyrosine Kinases/antagonists & inhibitors; Treatment Outcome |
| Tipo |
info:eu-repo/semantics/article article |
